$13.91
-0.260 (-1.83%)
At Close: Nov 17, 2025
InMode Ltd. $INMD Shares Sold by Acadian Asset Management LLC
03:16am, Friday, 14'th Nov 2025
Acadian Asset Management LLC lessened its holdings in InMode Ltd. (NASDAQ: INMD) by 40.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript
12:51pm, Wednesday, 05'th Nov 2025
InMode Ltd. ( INMD ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participant
InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins
07:00am, Wednesday, 05'th Nov 2025
YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results fo
InMode Appoints Michael Dennison as President of North America
08:05am, Monday, 03'rd Nov 2025
IRVINE, Calif. , Nov. 3, 2025 /PRNewswire/ -- InMode Ltd.
InMode to Participate in Upcoming Investor Conferences
08:30am, Thursday, 30'th Oct 2025
YOKNEAM, Israel , Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor co
D.A. Davidson & CO. Sells 1,376 Shares of InMode Ltd. $INMD
04:00am, Wednesday, 29'th Oct 2025
D.A. Davidson and CO. reduced its position in InMode Ltd. (NASDAQ: INMD) by 2.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Com
InMode: Discounted Valuation & Strong Fundamentals Make It A Buy
02:07pm, Monday, 27'th Oct 2025
InMode presents an appealing buy opportunity, trading near 52-week lows with strong fundamentals, innovative technology, and global expansion. INMD's minimally invasive platforms drive revenue growth,
Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd.
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders
08:15am, Tuesday, 09'th Sep 2025
Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026 Maintains Board Has Legal and Fiduciary Duty to Act in Best Interests of Shareholders MIAMI
InMode to Present at Baird 2025 Global Healthcare Conference
08:30am, Tuesday, 02'nd Sep 2025
YOKNEAM, Israel , Sept. 2, 2025 /PRNewswire/ -- InMode Ltd.
InMode to Participate in Upcoming Investor Conferences
08:30am, Tuesday, 05'th Aug 2025
YOKNEAM, Israel , Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor con
InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript
03:22pm, Wednesday, 30'th Jul 2025
InMode Ltd. (NASDAQ:INMD ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Cal
InMode (INMD) Q2 Earnings and Revenues Beat Estimates
09:11am, Wednesday, 30'th Jul 2025
InMode (INMD) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.34 per share a year ago.
InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins
07:00am, Wednesday, 30'th Jul 2025
YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results f
InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Wednesday, 23'rd Jul 2025
InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sign In
Buy INMD